ZFP811 inhibitors are a class of chemical compounds designed to selectively target and inhibit the function of the zinc finger protein 811 (ZFP811), a member of the zinc finger protein family. ZFP811 is part of a large family of transcription factors, which are proteins that can bind to specific sequences of DNA to regulate gene expression. Zinc finger proteins, including ZFP811, are characterized by the presence of zinc ion-coordinating motifs, which stabilize the protein structure and allow for precise interactions with DNA or other molecular partners. Inhibitors of ZFP811 typically work by disrupting the ability of this protein to bind to its DNA target sequences, thereby interfering with its role in modulating gene expression. These inhibitors may function through a variety of mechanisms, including competitive binding to the DNA binding site, altering the protein's conformation, or blocking essential interactions required for its activity.
The development of ZFP811 inhibitors often involves detailed studies of the structure and function of the zinc finger domains within the protein, as well as the DNA sequences that the protein targets. Advanced techniques such as molecular docking and computational chemistry are frequently used to design inhibitors that can specifically target the ZFP811-DNA interaction interface. Structural biology tools, like X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy, can provide detailed insights into the atomic-level interactions between ZFP811 and its inhibitors, guiding the optimization of these molecules. In addition, studies on ZFP811 inhibitors also explore their selectivity to ensure that the inhibition is specific to ZFP811 without affecting other members of the zinc finger protein family. These compounds are valuable tools for studying the role of ZFP811 in various biological processes, offering insights into transcriptional regulation, protein-DNA interactions, and zinc finger protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can alter gene expression, potentially affecting ZNF811. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting the methylation status of ZNF811 gene. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Another histone deacetylase inhibitor, altering chromatin structure and gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A DNA methyltransferase inhibitor, potentially modifying ZNF811 expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A BET bromodomain inhibitor, possibly influencing transcription factors including ZNF811. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A selective histone deacetylase inhibitor, affecting gene regulation and expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
A histone deacetylase inhibitor, could impact the expression of genes like ZNF811. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methyltransferase inhibitor, could affect the methylation status of ZNF811 gene regions. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
A potent histone deacetylase inhibitor, affecting gene expression broadly, including ZNF811. | ||||||
CPI-203 | 1446144-04-2 | sc-501599 | 1 mg | $170.00 | ||
A BET bromodomain inhibitor, which may impact the regulation of ZNF811 and associated genes. | ||||||